Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of alvespimycin hydrochloride
in treating patients with metastatic or unresectable solid tumors. Drugs used in
chemotherapy, such as alvespimycin hydrochloride, work in different ways to stop tumor cells
from dividing so they stop growing or die.